Anti-ATPase Inhibitory Factor 1 antibody [5E2D7] (ab110277)

Publishing research using ab110277? Please let us know so that we can cite the reference in this datasheet.

ab110277 has been referenced in 7 publications.

  • Matic I  et al. Neuroprotective coordination of cell mitophagy by the F1Fo-ATPase Inhibitory Factor 1 (IF1). Pharmacol Res N/A:N/A (2015). PubMed: 26484591
  • Mourier A  et al. Loss of LRPPRC causes ATP synthase deficiency. Hum Mol Genet N/A:N/A (2014). WB . PubMed: 24399447
  • Rossin F  et al. Transglutaminase 2 ablation leads to mitophagy impairment associated with a metabolic shift towards aerobic glycolysis. Cell Death Differ N/A:N/A (2014). PubMed: 25060553
  • Fujikawa M  et al. Assessing Actual Contribution of IF1, Inhibitor of Mitochondrial FoF1, to ATP Homeostasis, Cell Growth, Mitochondrial Morphology, and Cell Viability. J Biol Chem 287:18781-7 (2012). WB ; Human . PubMed: 22493494
  • Domenis R  et al. Glucose-modulated mitochondria adaptation in tumor cells: a focus on ATP synthase and inhibitor factor 1. Int J Mol Sci 13:1933-50 (2012). WB ; Human . PubMed: 22408432
  • Domenis R  et al. Mitochondrial bioenergetic profile and responses to metabolic inhibition in human hepatocarcinoma cell lines with distinct differentiation characteristics. J Bioenerg Biomembr 43:493-505 (2011). WB ; Human . PubMed: 21882038
  • Cortés-Hernández P  et al. ATP6 homoplasmic mutations inhibit and destabilize the human F1F0-ATP synthase without preventing enzyme assembly and oligomerization. J Biol Chem 282:1051-8 (2007). PubMed: 17121862

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"